<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Cardiology Product Guide &#187; high blood pressure</title>
	<atom:link href="http://blog.cardiologyproductguide.com/tag/high-blood-pressure/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.cardiologyproductguide.com</link>
	<description>A comprehensive guide to cardiology products for medical professionals </description>
	<lastBuildDate>Tue, 14 Jun 2011 11:39:11 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>Cialis’ active ingredient approved for a new use</title>
		<link>http://blog.cardiologyproductguide.com/2009/07/06/cialis-active-ingredient-approved-for-a-new-use/</link>
		<comments>http://blog.cardiologyproductguide.com/2009/07/06/cialis-active-ingredient-approved-for-a-new-use/#comments</comments>
		<pubDate>Tue, 07 Jul 2009 04:54:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diagnostics & Theraputics]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Adcirca]]></category>
		<category><![CDATA[Cialis]]></category>
		<category><![CDATA[erectile dysfunction]]></category>
		<category><![CDATA[high blood pressure]]></category>
		<category><![CDATA[Lilly]]></category>
		<category><![CDATA[pulmonary arterial hypertension]]></category>
		<category><![CDATA[tadalafil]]></category>
		<category><![CDATA[United Therapeutics]]></category>
		<guid isPermaLink="false">http://www.cardiologyproductguide.com/blog/2009/07/06/cialis%e2%80%99-active-ingredient-approved-for-a-new-use/</guid>
		<description><![CDATA[The FDA has approved tadalafil, the active ingredient in the erectile dysfunction drug Cialis, to improve exercise ability in people with pulmonary arterial hypertension, which is a rare, life-threatening lung disorder. This disorder causes high blood pressure in lungs. Tadalafil, manufactured by the drug company Lilly, will be available in the U.S. as Adcirca in [...]]]></description>
			<content:encoded><![CDATA[<p><img vspace="5" align="left" width="200" src="http://blog.cardiologyproductguide.com/files/2009/06/adcirca.png" hspace="5" height="113" />The FDA has approved tadalafil, the active ingredient in the erectile dysfunction drug Cialis, to improve exercise ability in people with pulmonary arterial hypertension, which is a rare, life-threatening lung disorder. This disorder causes high blood pressure in lungs. Tadalafil, manufactured by the drug company Lilly, will be available in the U.S. as Adcirca in August by United Therapeutics Corporation.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.cardiologyproductguide.com/2009/07/06/cialis-active-ingredient-approved-for-a-new-use/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

